Cited by 733Tryptophan and brain disordersNeuroinflammation and Neurodegeneration MechanismsStress Responses and Cortisol

The DOI matches its Crossref record; 263 of the 265 references it cites were found in a registry or an index.

Neuroinflammation and psychiatric illness

Open access

Najjar, Souhel, Pearlman, Daniel M, Alper, Kenneth, Najjar, Amanda, Devinsky, Orrin·2013·Journal of Neuroinflammation

DOI 10.1186/1742-2094-10-43PMC PMC3626880

Open this paper in CoChat — free account Open PDF

Abstract

Multiple lines of evidence support the pathogenic role of neuroinflammation in psychiatric illness. While systemic autoimmune diseases are well-documented causes of neuropsychiatric disorders, synaptic autoimmune encephalitides with psychotic symptoms often go under-recognized. Parallel to the link between psychiatric symptoms and autoimmunity in autoimmune diseases, neuroimmunological abnormalities occur in classical psychiatric disorders (for example, major depressive, bipolar, schizophrenia, and obsessive-compulsive disorders). Investigations into the pathophysiology of these conditions traditionally stressed dysregulation of the glutamatergic and monoaminergic systems, but the mechanisms causing these neurotransmitter abnormalities remained elusive. We review the link between autoimmunity and neuropsychiatric disorders, and the human and experimental evidence supporting the pathogenic role of neuroinflammation in selected classical psychiatric disorders. Understanding how psychosocial, genetic, immunological and neurotransmitter systems interact can reveal pathogenic clues and help target new preventive and symptomatic therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/1742-2094-10-43

Cites

263 of 263 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Influence of the ‘Th1-Th2 cytokine seesaw’ generated by glial cells and T lymphocytes on tryptophan/kynurenine metabolism-mediated serotonergic and glutamatergic abnormalities in major depressive disorder and schizophrenia. Influence of the ’Th1-Th2 seesaw’ generated by glial cells and T lymphocytes (first of three bracketed sections) on the enzymes controlling tryptophan/kynurenine metabolism (second of three bracketed sections) leading to serotonergic and glutamatergic abnormalities in major depressive disorder and schizophrenia (third of three bracketed sections). Microglial and astroglial IDO is the rate-limiting enzyme catalyzing the conversion of tryptophan to KYN and serotonin to 5HTT. KMO, which is solely expressed by microglia, is the rate-limiting enzyme catalyzing the conversion of KYN to 3-OH-KYN. TDO, which is solely expressed by astroglia, is the rate-limiting enzyme catalyzing the conversion of tryptophan to KYN. KAT, expressed primarily in astroglial processes, is the rate-limiting enzyme catalyzing the conversion of KYN to KYNA. The microglial enzymes IDO and KMO are upregulated by Th1 cytokines and downregulated by Th2 cytokines. An imbalance of the ‘Th1-Th2 seesaw’ shifts kynurenine catabolism either towards microglial quinolinic acid (NMDA agonist) as in major depressive disorder, or towards astroglial kynurenic acid (NMDA antagonist) as in schizophrenia. 5HIAA, 5-Hydroxyindoleacetic acid; α7nAchR, alpha 7 nicotinic acetylcholine receptors; BBB, blood–brain barrier; IDO, indoleamine-2,3-dioxygenase; IL, interleukin; IFN-γ, interferon gamma; KAT, kynurenine aminotransferase; KMO, kynurenine 3-monooxygenase; KYN, kynurenine; KYNA, kynurenic acid; NMDAR, N-methyl-D-aspartate receptor; TNF-α, tumor necrosis factor alpha; T regs, CD4+CD25+FOXP3+ T regulatory cells; TDO, tryptophan-2,3-dioxygenase; Th, T-helper.CC BY · PubMed Central

Figure 2 Hypothesis of MDD: excess CNS glutamate may contribute to excess Th1- response promoting neuroprotective microglia. Peripheral resting T lymphocytes constitutively express mGluR5. Activated T lymphocytes, but not resting T lymphocytes, can cross the BBB. In the animal models, the interaction between TCR of activated T lymphocytes and their cognate antigen presenting cells downregulates mGluR5 and induces mGluR1 expressions. Experimental data suggest that excess glutamate can bind to lymphocytic mGluR1 receptors, promoting production of Th1 cytokines. Hypothesis: In some MDD patients, parallel to experimental data, binding of excess CNS glutamate to induced lymphocytic mGluR1 receptors may contribute to an excess Th1 response, including IFN-γ. We further hypothesize that IFN-γ in a small quantity, similar to its in vitro effects on microglia, may induce microglial expression of MHC-II and EAAT-2, allowing microglia to serve as cognate antigen presenting cells and to provide glutamate reuptake function, thereby transforming harmful microglia into neuroprotective phenotype that participate in eliminating excess extracellular glutamate and reducing its excitotoxicity. Therefore, we hypothesize that excess Th1 response in some MDD patients is a double-edged sword; promoting harmful inflammation and serving as a beneficial counter-regulatory mechanism that may limit excess glutamate-related neuroexcitotoxicity? AMPA, 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)-propanoic acid; APC, antigen presenting cell; BBB, blood–brain barrier; CNS, central nervous system, EAAT, excitatory amino acid transporter; IDO, indoleamine-2,3-dioxygenase; IFN-γ, interferon gamma; IL, interleukin; KMO, kynurenine 3-monooxygenase; mGluR1/5, metabotropic glutamate receptors 1 and 5; MHC II, major histocompatibility complex class 2; NMDA, N-methyl-D-aspartate; NO, nitric oxide; NR1, glycine site; QA, quinolinic acid; TCR, T-cell receptor; Th, T-helper; TNF-α, tumor necrosis factor alpha.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Items 201–263 of 263

Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus
Byne, W. M., KIDKARDNEE, S., TATUSOV, A., Yiannoulos, G., Buchsbaum, M. S., & HAROUTUNIAN, V. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.03.029 · Cited by 73
Anti-inflammatory signaling in schizophrenia
Meyer, U. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.014 · Cited by 72
Association Between Clinical Depression and Endothelial Function Measured by Forearm Hyperemic Reactivity
Lavoie, K., Pelletier, R., Arsenault, A., Dupuis, J., & Bacon, S. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181c2d6b8 · Cited by 71
Oxidative stress and glutathione response in tissue cultures from persons with major depression
Gibson, S. A., Korade, Ž., & Shelton, R. C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.06.008 · Cited by 71
Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls
Laske, C., Zank, M., Klein, R., Stransky, E., Batra, A., Buchkremer, G., & Schott, K. J. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.04.023 · Cited by 71
A preliminary randomized double–blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive–compulsive disorder
Sayyah, M., Boostani, H., Pakseresht, S., & Malayeri, A. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.01.019 · Cited by 70
Protein Array Profiling of Tic Patient Sera Reveals a Broad Range and Enhanced Immune Response against Group A Streptococcus Antigens
Bombaci, M., Grifantini, R., Mora, M., Reguzzi, V., Petracca, R., Meoni, E., Balloni, S., Zingaretti, C., Falugi, F., Manetti, A. G. O., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006332 · Cited by 70
Decreased Blood Levels of Tumor Necrosis Factor-Alpha in Patients with Obsessive-Compulsive Disorder
Monteleone, P., Catapano, F., Fabrazzo, M., Tortorella, A. A. V., & Maj, M. (1998) · Neuropsychobiology · doi:10.1159/000026500 · Cited by 67
Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia
Coughlin, J. M., Ishizuka, K., Kano, S. I., Edwards, J. A., Seifuddin, F. T., Shimano, M. A., Daley, E. L., Zandi, P. P., Leweke, F. M., Cascella, N. G., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.6 · Cited by 66
Plasma Interleukin-1β and Tumor Necrosis Factor Concentrations in Obsessive–Compulsive Disorders
Brambilla, F., Perna, G., Bellodi, L., Arancio, C., Bertani, A., Perini, G., Carraro, C., & Gava, F. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00495-7 · Cited by 65
Spontaneously Resolving Seronegative Autoimmune Limbic Encephalitis
Najjar, S., Pearlman, D. M., Zagzag, D., & Devinsky, O. (2011) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3182248193 · Cited by 64
Self-citation
The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms
Rotgé, J., Aouizerate, B., Tignol, J.-P., Bioulac, B. H., Burbaud, P., & Guehl, D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.043 · Cited by 63
Human CD8+ T cells and NK cells express and secrete S100B upon stimulation
Steiner, J. H., Marquardt, N., Pauls, I., Schiltz, K., Rahmoune, H., Bahn, S., Bogerts, B., Schmidt, R. E., & Jacobs, R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.015 · Cited by 62
The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia
Zhang, X., Zhou, D. F., Cao, L. Y., Zhang, P. Y., Wu, G. Y., & Shen, Y. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00004 · Cited by 61
Regulation of Interleukin-10 Gene Expression: Possible Mechanisms Accounting for Its Upregulation and for Maturational Differences in Its Expression by Blood Mononuclear Cells
Le, T. V., Leung, L., Carroll, W. L., & Schibler, K. R. (1997) · Blood · doi:10.1182/blood.v89.11.4112 · Cited by 61
Possible antidepressant effect of minocycline
Levine, J., Cholestoy, A., & Zimmerman, J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.582b · Cited by 59
Neuroimaging of frontal–limbic dysfunction in schizophrenia and epilepsy-related psychosis: Toward a convergent neurobiology
Butler, T., Weisholtz, D. S., Isenberg, N., Harding, E., Epstein, J., Stern, E. R., & Silbersweig, D. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.11.004 · Cited by 58
Refractory Epilepsy Associated With Microglial Activation
Najjar, S., Pearlman, D. M., Miller, D. C., & Devinsky, O. (2011) · The Neurologist · doi:10.1097/nrl.0b013e31822aad04 · Cited by 58
Self-citation
Cytokines in Bipolar Disorder: Recent Findings, Deleterious Effects But Promise for Future Therapeutics
Brietzke, E., Stabellini, R., Grassi-Oliveira, R., & Lafer, B. (2011) · CNS Spectrums · doi:10.1017/s1092852912000338 · Cited by 57
Immunological alterations in adult obsessive-compulsive disorder
Marazziti, D., Presta, S., Pfanner, C., Gemignani, A., Rossi, A., Sbrana, S., Rocchi, V., Ambrogi, F., & Cassano, G. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00371-0 · Cited by 57
Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis
Tofaris, G. K., Irani, S. R., Cheeran, B., Baker, I., Cader, M. Z., & Vincent, A. C. (2012) · Neurology · doi:10.1212/wnl.0b013e31825f0522 · Cited by 57
Minocycline Augmentation of Pharmacotherapy in Obsessive-Compulsive Disorder
Rodríguez, C. I., Bender, J., Marcus, S. M., Snape, M. F., Rynn, M. A., & Simpson, H. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09l05805blu · Cited by 56
Antibodies to the glutamate receptor in mania
Dickerson, F., Stallings, C. R., Vaughan, C., Origoni, A. E., Khushalani, S., & Yolken, R. H. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01028.x · Cited by 55
S100B in schizophrenia: an update.
Rothermundt, M., Ahn, J. N., & Jörgens, S. (2009) · PubMed · Cited by 51
Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals
BRAUCH, R., ADNANELMASRI, M., PARKERJR, J., & El‐Mallakh, R. S. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.08.015 · Cited by 50
EAAT expression by macrophages and microglia: still more questions than answers
Gras, G. S., Samah, B., Hubert, A., Léone, C., Porcheray, F., & Rimaniol, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0866-6 · Cited by 48
Beneficial Effects of Exogenous Tetrahydrobiopterin on Left Ventricular Remodeling After Myocardial Infarction in Rats The Possible Role of Oxidative Stress Caused by Uncoupled Endothelial Nitric Oxide Synthase
Masano, T., Kawashima, S., Toh, R., Satomi‐Kobayashi, S., Shinohara, M., Takaya, T., Sasaki, N., Takeda, M., Tawa, H., Yamashita, T., et al. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0072 · Cited by 47
Glutamate–Dopamine Crosstalk in the Rat Prefrontal Cortex is Modulated by Alpha7 Nicotinic Receptors and Potentiated by PNU-120596
Livingstone, P. D., Dickinson, J. A., Srinivasan, J., Kew, J. N. C., & Wonnacott, S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9232-5 · Cited by 47
Disgust affects TNF-α, IL-6 and noradrenalin levels in patients with obsessive–compulsive disorder
Fluitman, S. B. A. H. A., Denys, D. A. J. P., Heijnen, C. J., & Westenberg, H. G. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.12.005 · Cited by 46
Fluoxetine Effect on Aortic Nitric Oxide-Dependent Vasorelaxation in the Unpredictable Chronic Mild Stress Model of Depression in Mice
Isingrini, E., Belzung, C., Freslon, J., Machet, M., & Camus, V. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31823a43e0 · Cited by 46
Increased serum S100B in never-medicated and medicated schizophrenic patients
Zhang, X. Y., Xiu, M. H., Song, C., Chen, D. C., Wu, G. Y., Haile, C. N., Kosten, T. A., & Kosten, T. R. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.023 · Cited by 46
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder
Uher, R., Carver, S., Power, R. A., Mors, O., Maier, W., Rietschel, M., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291712000190 · Cited by 45
Prevalence of anti-basal ganglia antibodies in adult obsessive–compulsive disorder: cross-sectional study
Nicholson, T. R., Ferdinando, S., Krishnaiah, R., Anhoury, S., Lennox, B., Mataix‐Cols, D., Cleare, A. J., Veale, D. M., Drummond, L. M., Fineberg, N. A., et al. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.092007 · Cited by 43
Lipopolysaccharide-induced cytokine production in obsessive–compulsive disorder and generalized social anxiety disorder
Fluitman, S. B. A. H. A., Denys, D. A. J. P., Vulink, N. C. C., Schutters, S. I. J., Heijnen, C. J., & Westenberg, H. G. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.008 · Cited by 42
Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?
García‐Bueno, B., Perez‐Nievas, B. G., & Leza, J. C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000970 · Cited by 41
[Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia].
Vm, V., Uranova, N. A., Vi, R., & Dd, O. (2004) · PubMed · Cited by 40
Macrophage migration inhibitory factor activates cyclooxygenase 2–prostaglandin E2 in cultured spinal microglia
Wang, F., Wu, H., Xu, S., Guo, X., Yang, J., & Shen, X. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.07.1821 · Cited by 39
Acute psychiatric illness in a young woman: an unusual form of encephalitis
Parratt, K. L., Allan, M., Lewis, S. J. G., Dalmau, J. O., Halmagyi, G. M., & Spies, J. M. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02787.x · Cited by 37
Ritmo luz/oscuridad de las citocinas proinflamatorias en el infarto agudo de miocardio
Rodríguez, A. D., González, P., García, M. J., de la Rosa, A., Vargasa, M., & Marrero, F. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76916-4 · Cited by 35
Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: Age-dependent changes
Miguel-Hidalgo, J. J., Overholser, J. C., Jurjus, G., Meltzer, H. Y., Dieter, L., Konick, L. C., Stockmeier, C. A., & Rajkowska, G. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.052 · Cited by 34
Anti-brain antibodies in adult patients with obsessive–compulsive disorder
Maina, G., Albert, U., Bogetto, F., Borghese, C., Berro, A. C., Mutani, R., Rossi, F., & Vigliani, M. C. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.019 · Cited by 34
Functional Polymorphism of Cyclooxygenase-2 Gene (G–765C) in Depressive Patients
Gałecki, P., Florkowski, A., Bieńkiewicz, M., & Szemraj, J. (2010) · Neuropsychobiology · doi:10.1159/000317284 · Cited by 32
Risk variants in the S100B gene, associated with elevated S100B levels, are also associated with visuospatial disability of schizophrenia
Zhai, J., Zhang, Q., Cheng, L., Chen, M., Wang, K., Liu, Y., Deng, X., Chen, X., Shen, Q., Xu, Z., et al. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.004 · Cited by 32
Neuropathological Similarities and Differences between Schizophrenia and Bipolar Disorder: A Flow Cytometric Postmortem Brain Study
Hayashi, Y., Nihonmatsu-Kikuchi, N., Hisanaga, S.-I., Yu, X.-J., & Tatebayashi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033019 · Cited by 31
Association study between functional polymorphisms in the TNF-alpha gene and obsessive-compulsive disorder
Cappi, C., Muniz, R. K., Sampaio, A. S., Cordeiro, Q., Brentani, H., Palácios, S. A., Marques, A. H., Vallada, H., Miguel, E. C., Guilherme, L., et al. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000200003 · Cited by 31
Glutamic Acid Decarboxylase Autoantibody Syndrome Presenting as Schizophrenia
Najjar, S., Pearlman, D. M., Zagzag, D., Golfinos, J. G., & Devinsky, O. (2012) · The Neurologist · doi:10.1097/nrl.0b013e318247b87d · Cited by 30
Self-citation
Is the Gly82Ser polymorphism in the RAGE gene relevant to schizophrenia and the personality trait psychoticism?
Suchankova, P., Klang, J., Cavanna, C., Holm, G., Nilsson, S., Jönsson, E. G., & Ekman, A. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110024 · Cited by 27
STREPTOCOCCAL INFECTION, TOURETTE SYNDROME, AND OCD: IS THERE A CONNECTION? PANDAS: HORSE OR ZEBRA?
Swedo, S. E. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d8a638 · Cited by 25
S100B gene polymorphisms predict prefrontal spatial function in both schizophrenia patients and healthy individuals
Zhai, J., Cheng, L., Dong, J., Shen, Q., Zhang, Q., Chen, M., Gao, L., Chen, X., Wang, K., Deng, X., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.09.029 · Cited by 22
Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: An underdiagnosed entity?
Najjar, S., Pearlman, D. M., Najjar, A., Ghiasian, V., Zagzag, D., & Devinsky, O. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.03.038 · Cited by 21
Self-citation
Reduced glial density and neuronal volume in major depressive disorder and schizophrenia in the anterior cingulate cortex
Cotter, D., Mackay, D., Beasley, C., Kerwin, R. W., & Everall, I. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)90552-8 · Cited by 15
Does Concomitant Use of NSAIDs Reduce the Effectiveness of Antidepressants?
Shelton, R. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070924 · Cited by 12
Grooming and Growing with Microglia
Antony, J. M. (2010) · Science Signaling · doi:10.1126/scisignal.3147jc8 · Cited by 11
Tumor necrosis factor-alpha gene is not associated with obsessive-compulsive disorder
Zai, G. C., Arnold, P. D., Burroughs, E., Richter, M. A., & Kennedy, J. L. (2006) · Psychiatric Genetics · doi:10.1097/01.ypg.0000185026.12687.92 · Cited by 10
Gadolinium-DTPA enhanced gradient echo magnetic resonance scans in first episode of psychosis and chronic schizophrenic patients
Szymanski, S., Ashtari, M., Zito, J. L., Degreef, G., Bogerts, B., & Lieberman, J. A. (1991) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(91)90011-e · Cited by 10
[Case report of anti-NMDA receptor encephalitis suspected of schizophrenia].
Suzuki, Y., Kurita, T., Sakurai, K., Takeda, Y., & Koyama, T. (2009) · PubMed · Cited by 9
Cell density in the planum temporale in schizophrenia
Simper, R. C., Chance, S. A., Esiri, M. M., Harrison, P. J., & Crow, T. J. (2002) · Schizophrenia Research · Cited by 9
The density, size and spatial pattern distribution of neurons and glia in area 9 prefrontal cortex in schizophrenia, bipolar disorder and major depression
Cotter, D., Mackay, D., Beasley, C. L., Everall, I., & Landau, S. (2002) · Research Portal (King's College London) · Cited by 8
Biological Research in Anxiety Disorders
Uhde, T. W., & Singareddy, R. K. (2002) · Wiley eBooks · doi:10.1002/0470846461.ch8 · Cited by 7
Neurosyphilis as a Cause of Cognitive Decline and Psychiatric Symptoms at Younger Age
Keskin, G., Sunter, G., Midi, İ., & Tuncer, N. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.4.jnpe41 · Cited by 6
Uncommon Cause of Psychotic Behavior in a 9-Year-Old Girl: A Case Report
Putten, W. K. V., Hachimi-Idrissi, S., Jansen, A., Gorp, V. V., & Huyghens, L. (2012) · Case Reports in Medicine · doi:10.1155/2012/358520 · Cited by 2
Encephalitis and schizophrenia: a matter of words
O'Loughlin, K., Ruge, P., & McCauley, M. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.201.1.74 · Cited by 2
In vitro evidence for the brain glutamate efflux hypothesis: brain endothelial cells co-cultured with astrocytes display a polarized brain-to-blood transport of glutamate
Helms, H. C. C., Madelung, R., Groth, S., Waagepetersen, H. S., Nielsen, C. U., & Brodin, B. (2012) · University of Southern Denmark Research Portal (University of Southern Denmark) · Cited by 2

Research works printed but not linked: 9

Krishnan R: Unipolar depression in adults: epidemiology, pathogenesis, and neurobiology. In UpToDate. Edited by Basow DS. Waltham, MA: UpToDate; 2013.
Stovall J: Bipolar disorder in adults: epidemiology and diagnosis. In UpToDate. Edited by Basow DS. UpToDate: Waltham; 2013.
Fischer BA, Buchanan RW: Schizophrenia: epidemiology and pathogenesis. In UpToDate. Edited by Basow DS. Waltham, MA: UpToDate; 2013.
Doyle C, Deakin JFW: Fewer astrocytes in frontal cortex in schizophrenia, depression and bipolar disorder. Schizophrenia Res 2002, 53:106.
Uranova NA, Orlovskaya DD, Vostrikov VM, Rachmanova VI: Decreased density of oligodendroglial satellites of pyramidal neurons in layer III in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 2002, 53:107.
Najjar S, Pearlman D, Devinsky O, Najjar A, Nadkarni S, Butler T, Zagzag D: Neuropsychiatric autoimmune encephalitis with negative VGKC-complex, NMDAR, and GAD autoantibodies: a case report and literature review, forthcoming. Cogn Behav Neurol in press
Si X, Miguel-Hidalgo JJ, Rajkowska G: GFAP expression is reduced in the dorsolateral prefrontal cortex in depression. In Society for Neuroscience; 2003 . Neuroscience Meeting Planne: New Orleans; 2003.
Legutko B, Mahajan G, Stockmeier CA, Rajkowska G: White matter astrocytes are reduced in depression. In Society for Neuroscience . Neuroscience Meeting Planner: Washington, DC; 2011.
Butler T, Maoz A, Vallabhajosula S, Moeller J, Ichise M, Paresh K, Pervez F, Friedman D, Goldsmith S, Najjar S, Osborne J, Solnes L, Wang X, French J, Thesen T, Devinsky O, Kuzniecky R, Stern E, Silbersweig D: Imaging inflammation in a patient with epilepsy associated with antibodies to glutamic acid decarboxylase [abstract]. In Am Epilepsy Society Abstracts, Volume 2. Baltimore: American Epilepsy Society; 2011:191.

Sorted by citations

Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.037 · Cited by 1,804
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 567

See all 733

Authors: Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O.
Affiliations: NYU Langone Health (US)
Dartmouth Institute for Health Policy and Clinical Practice (US)
Corresponding author: Najjar, Souhel
ORCID: Najjar, Souhel
Pearlman, Daniel M
Alper, Kenneth
Devinsky, Orrin
Venue: Journal of Neuroinflammation
Publisher: Springer Science and Business Media LLC
Published: 2013-04-01
Volume: 10
Issue: 1
Pages: 43-43
ISSN: 1742-2094 (ISSN-L)
DOI: 10.1186/1742-2094-10-43
PMC: PMC3626880
OpenAlex: W2097086441
Cited by: 733
References: 265
Citations by year: 2026: 28 · 2025: 59 · 2024: 73 · 2023: 56 · 2022: 74 · 2021: 65 · 2020: 54 · 2019: 57 · 2018: 67 · 2017: 54 · 2016: 53 · 2015: 46 · 2014: 36 · 2013: 10
FWCI: 3.15
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/2.0 (unspecified)
Locations: Journal of Neuroinflammation (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords: neuroinflammation, mental illness, autoimmunity, psychosis, major depressive disorder, bipolar disorder, schizophrenia, obsessive-compulsive disorder, glutamatergic system, monoaminergic systems, neurotransmitter dysregulation, neuroimmunology
MeSH terms: Animals, Autoimmune Diseases, Mental Disorders, Humans, Inflammation, Autoimmunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroinflammation and psychiatric illness

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks